A groundbreaking shift in our drug policy has taken place, as the authorities permit the use of psilocybin hallucinogens for therapeutic treatment. Previously, these substances were strictly restricted, but a mounting body of research suggests they potentially offer benefits for emotional illnesses like PTSD. This development represents a major ste